Table 1.
Number (%), Average or Median (IQR)† | ||||
---|---|---|---|---|
n | Fecal diversion group | Supported natural defecation group | p value†† | |
Gender [female] | 71/392 | 14 (19.9) | 97 (24.7) | 0.36 |
Age [years] | 71/392 | 54 (44; 65) | 53 (43; 63) | 0.54 |
Body mass index [kg/m2] | 71/381 | 26.3 (22.1; 29.4)* | 24.2 (20.5; 27.4) | 0.04 |
Duration since SCI [months] | 59/346 | 280 (97; 406) | 219 (71.8; 380.3) | 0.11 |
Aetiology of SCI** | 69/362 | – | ||
Trauma | 36 (52.2) | 245 (67.7) | ||
Infection | 2 (2.9) | 10 (2.8) | ||
Neoplasia | 0 (0) | 13 (3.6) | ||
Other | 31 (44.9) | 94 (26.0) | ||
ASIA classification | 68/383 | 0.56 | ||
Stage A | 62 (91.2) | 340 (88.8) | ||
Stage B | 6 (8.8) | 43 (11.2) | ||
Stage C | 0 (0) | 0 (0) | ||
Stage D | 0 (0) | 0 (0) | ||
Stage E | 0 (0) | 0 (0) | ||
Comorbidities | 71/391 | 68 (95.8)* | 337 (86.2) | 0.02 |
Smoking habit | 60/346 | 0.64 | ||
Active smoker | 17 (28.3) | 88 (25.4) | ||
Non- smoker | 43 (71.7) | 258 (74.6) | ||
Alcohol consumption | 71/392 | 5 (8.5) | 25 (7.4) | 0.76 |
ASA classification††** | 71/392 | 0.002 | ||
Stage 1 | 0 (0) | 0 (0) | ||
Stage 2 | 22 (31) | 190 (48.5) | 0.004 | |
Stage 3 | 46 (64.8) | 199 (50.8) | 0.03 | |
Stage 4 | 3 (4.2) | 3 (0.8) | 0.002 | |
Stage 5 | 0 (0) | 0 (0) | ||
Presence of a stoma | 71/392 | 71 (100) | 0 (100) | – |
End-Colostomy | 26 (36.6) | 0 (0) | ||
Loop-Ileostomy | 17 (23.9) | 0 (0) | ||
Time between stoma surgery and current ulcer [months] | 29 | 40 (2.3; 156.1) | n/a | – |
Adverse event during stoma surgery | 44 | 11 (25) | n/a | – |
Previously surgical until wound healing | 66/379 | 1 (0; 2) | 1 (0; 2) | 0.31 |
Previously surgical ulcer procedures | 71/392 | 39 (54.9) | 207 (52.8) | 0.74 |
Severity Ulcer | 71/392 | 71 (100)* | 392 (100) | 0.02 |
Stage 3 | 36 (50.7) | 255 (65.1) | ||
Stage 4 | 35 (49.3) | 137 (34.9) | ||
Size Ulcer [cm2] | 60/329 | 25 (10.5; 71.5)* | 20 (9; 35) | 0.04 |
ASA American Society of Anesthesia, ASIA American Spinal Injury Association, SCI spinal cord injury.
†as appropriate.
††regardless SCI. Chi2-Test or Mann–Whitney U test, as appropriate.
*significant with p < 0.05. **significant with p < 0.01.